GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tissue Repair Ltd (ASX:TRP) » Definitions » Net Income From Continuing Operations

Tissue Repair (ASX:TRP) Net Income From Continuing Operations : A$-4.44 Mil (TTM As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Tissue Repair Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Tissue Repair's net income from continuing operations for the six months ended in Dec. 2024 was A$-2.56 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Dec. 2024 was A$-4.44 Mil.

Tissue Repair Net Income From Continuing Operations Historical Data

The historical data trend for Tissue Repair's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tissue Repair Net Income From Continuing Operations Chart

Tissue Repair Annual Data
Trend Jun22 Jun23 Jun24
Net Income From Continuing Operations
-6.84 -4.17 -4.14

Tissue Repair Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Net Income From Continuing Operations Get a 7-Day Free Trial -3.15 -1.02 -2.26 -1.88 -2.56

Tissue Repair Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-4.44 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tissue Repair Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tissue Repair Ltd (ASX:TRP) » Definitions » Net Income From Continuing Operations
Comparable Companies
ASX:AVE ASX:1AI ASX:MEM ASX:ACR ASX:IMC ASX:RNV ASX:NSB ASX:CHM ASX:IXC ASX:ZLD VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
255 Pitt Street, Level 10, Sydney, NSW, AUS, 2000
Website
https://www.tissuerepair.com.au
Tissue Repair Ltd is a clinical-stage biopharmaceutical company engaged in development of wound healing products for chronic wounds and the aftercare of cosmetic procedures, with the potential for further development of related technologies.